Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools.
Randomized controlled trial · Sci Transl Med · 2017. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools.
Lamberth K, Reedtz-Runge SL, Simon J et al.
Sci Transl Med · 2017
- PubMed ID
- 28077675
- Record checked
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.